Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 359 (9313), 1221-31

Multiple Sclerosis


Multiple Sclerosis

Alastair Compston et al. Lancet.

Erratum in

  • Lancet 2002 Aug 24;360(9333):648


Multiple sclerosis is the prototype inflammatory autoimmune disorder of the central nervous system and, with a lifetime risk of one in 400, potentially the most common cause of neurological disability in young adults. As with all complex traits, the disorder results from an interplay between as yet unidentified environmental factors and susceptibility genes. Together, these factors trigger a cascade of events, involving engagement of the immune system, acute inflammatory injury of axons and glia, recovery of function and structural repair, post-inflammatory gliosis, and neurodegeneration. The sequential involvement of these processes underlies the clinical course characterised by episodes with recovery, episodes leaving persistent deficits, and secondary progression. The aim of treatment is to reduce the frequency, and limit the lasting effects, of relapses, relieve symptoms, prevent disability arising from disease progression, and promote tissue repair. Despite limited success in each of these categories, everyone touched by multiple sclerosis looks for a better dividend from applying an improved understanding of the pathogenesis to clinical management.

Similar articles

  • Multiple Sclerosis
    A Compston et al. Lancet 372 (9648), 1502-17. PMID 18970977.
    Multiple sclerosis is primarily an inflammatory disorder of the brain and spinal cord in which focal lymphocytic infiltration leads to damage of myelin and axons. Initial …
  • Interferon-beta1a Treatment for Multiple Sclerosis
    M Sandberg-Wollheim. Expert Rev Neurother 5 (1), 25-34. PMID 15853471. - Review
    Although multiple sclerosis is probably the most common cause of neurologic disability in young adults, the cause is unknown, the prognosis uncertain and available treatm …
  • Neurology. 4: Multiple Sclerosis
    MP Pender. Med J Aust 172 (11), 556-62. PMID 10920756. - Review
    Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS) and a common cause of disability in young adults; it is most l …
  • Neuronal Injury in Chronic CNS Inflammation
    E Zindler et al. Best Pract Res Clin Anaesthesiol 24 (4), 551-62. PMID 21619866. - Review
    Currently, Glatiramer acetate (GA) and the interferon-β (IFN-β) variants are established as first-line disease modifying treatments that reduce the relapse rate, ameliora …
  • New Options for Early Treatment of Multiple Sclerosis
    M Tintoré. J Neurol Sci 277 Suppl 1, S9-S11. PMID 19200870. - Review
    It is now possible to diagnose patients with multiple sclerosis earlier than previously due to the integration of MRI parameters into the diagnostic criteria. This provid …
See all similar articles

Cited by 470 PubMed Central articles

See all "Cited by" articles

Publication types

LinkOut - more resources